Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
The effects of amlodipine on exercise performance in mild to moderate essential hypertensives
The effect of the long acting dihydropyridine calcium channel antagonist, amlodipine, on the exercise performance of hypertensive patients is not known. The aim of this study was to determine the effects of amlodipine on maximal (MAX), prolonged submaximal (PSX) and on skeletal muscle function (SMF)...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
MRC/UCT RU for Exercise and Sport Medicine
2018
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867614460166799360 |
|---|---|
| access_status_str | Open Access |
| author | Gillies, Hunter Campbell |
| author2 | Derman, Wayne |
| author_browse | Derman, Wayne Gillies, Hunter Campbell |
| author_facet | Derman, Wayne Gillies, Hunter Campbell |
| author_sort | Gillies, Hunter Campbell |
| collection | Thesis |
| description | The effect of the long acting dihydropyridine calcium channel antagonist, amlodipine, on the exercise performance of hypertensive patients is not known. The aim of this study was to determine the effects of amlodipine on maximal (MAX), prolonged submaximal (PSX) and on skeletal muscle function (SMF) in patients with mild hypertension. In a double-blind randomised crossover trial, ten physically active hypertensive patients performed i) graded exercise to exhaustion for determination of maximal oxygen consumption (VO₂ₘₐₓ), peak heart rate (HR) and systolic blood pressure (SBP); ii) PSX at 75% VO₂ₘₐₓ to determine, cardiorespiratory responses, cardiac output (Q), blood lactate [La], free fatty acid [FFA], glucose [G] concentrations and ratings of perceived exertion (RPE), and iii) tests of isometric SMF including maximal voluntary contraction (MVC) and time to fatigue (TTF) during repetitve isometric MVC's. Tests were performed following two week ingestion of amlodipine (5 mg daily) or placebo seperated by a two week washout period. Resting SBP was decreased following ingestion of amlodipine (142 ± 13 vs l33 ± 12 mmHg; vs placebo: [mean± SD]; P<0.05). However, VO₂ₘₐₓ ( 31 ± 5 vs 33 ± 5 mlO₂.kg.min⁻¹ ; amlodipine vs placebo), peak heart rate ( 167 ± 12 vs 165 ± l6b.min⁻¹;amlodipine vs placebo)and peak SBP(l8l ±21 vs 170± 16mmHg; amlodipine vs placebo) were not reduced following ingestion of amlodipine. Submaximal cycling time. VO₂, Q, BP, HR, ventilation, RPE, [FFA], [La] and [G] during PSX were unaltered following ingestion of amlodipine. Similarly ingestion of amlodipine did not alter tests of isometric SMF. These data suggest that: i) ingestion of amlodipine lowers resting SBP but does not alter the normal haemodynamic response during exercise; ii) MAX, PSX exercise performance and SMF are unaltered following ingestion of amlodipine in athletic hypertensive patients. These findings suggest that the regulatory mechanisms which maintain haemodynamic homeostasis during maximal and submaximal exercise are not influenced by ingestion of amlodipine in athletic hypertensive patients. |
| format | Thesis |
| id | oai:open.uct.ac.za:11427/26977 |
| institution | University of Cape Town (South Africa) |
| language | eng |
| last_indexed | 2026-06-10T12:52:23.610Z |
| license_str | Not specified — see source repository |
| provenance_str_mv | Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository |
| publishDate | 2018 |
| publishDateRange | 2018 |
| publishDateSort | 2018 |
| publisher | MRC/UCT RU for Exercise and Sport Medicine |
| publisherStr | MRC/UCT RU for Exercise and Sport Medicine |
| record_format | dspace |
| source_str | UCTD — University of Cape Town Open Access Repository |
| spelling | oai:open.uct.ac.za:11427/26977 The effects of amlodipine on exercise performance in mild to moderate essential hypertensives Gillies, Hunter Campbell Derman, Wayne Sports Science The effect of the long acting dihydropyridine calcium channel antagonist, amlodipine, on the exercise performance of hypertensive patients is not known. The aim of this study was to determine the effects of amlodipine on maximal (MAX), prolonged submaximal (PSX) and on skeletal muscle function (SMF) in patients with mild hypertension. In a double-blind randomised crossover trial, ten physically active hypertensive patients performed i) graded exercise to exhaustion for determination of maximal oxygen consumption (VO₂ₘₐₓ), peak heart rate (HR) and systolic blood pressure (SBP); ii) PSX at 75% VO₂ₘₐₓ to determine, cardiorespiratory responses, cardiac output (Q), blood lactate [La], free fatty acid [FFA], glucose [G] concentrations and ratings of perceived exertion (RPE), and iii) tests of isometric SMF including maximal voluntary contraction (MVC) and time to fatigue (TTF) during repetitve isometric MVC's. Tests were performed following two week ingestion of amlodipine (5 mg daily) or placebo seperated by a two week washout period. Resting SBP was decreased following ingestion of amlodipine (142 ± 13 vs l33 ± 12 mmHg; vs placebo: [mean± SD]; P<0.05). However, VO₂ₘₐₓ ( 31 ± 5 vs 33 ± 5 mlO₂.kg.min⁻¹ ; amlodipine vs placebo), peak heart rate ( 167 ± 12 vs 165 ± l6b.min⁻¹;amlodipine vs placebo)and peak SBP(l8l ±21 vs 170± 16mmHg; amlodipine vs placebo) were not reduced following ingestion of amlodipine. Submaximal cycling time. VO₂, Q, BP, HR, ventilation, RPE, [FFA], [La] and [G] during PSX were unaltered following ingestion of amlodipine. Similarly ingestion of amlodipine did not alter tests of isometric SMF. These data suggest that: i) ingestion of amlodipine lowers resting SBP but does not alter the normal haemodynamic response during exercise; ii) MAX, PSX exercise performance and SMF are unaltered following ingestion of amlodipine in athletic hypertensive patients. These findings suggest that the regulatory mechanisms which maintain haemodynamic homeostasis during maximal and submaximal exercise are not influenced by ingestion of amlodipine in athletic hypertensive patients. 2018-01-25T13:54:44Z 2018-01-25T13:54:44Z 1997 Master Thesis Masters MSc (Med) http://hdl.handle.net/11427/26977 eng application/pdf MRC/UCT RU for Exercise and Sport Medicine Faculty of Health Sciences University of Cape Town |
| spellingShingle | Sports Science Gillies, Hunter Campbell The effects of amlodipine on exercise performance in mild to moderate essential hypertensives |
| thesis_degree_str | Master's |
| title | The effects of amlodipine on exercise performance in mild to moderate essential hypertensives |
| title_full | The effects of amlodipine on exercise performance in mild to moderate essential hypertensives |
| title_fullStr | The effects of amlodipine on exercise performance in mild to moderate essential hypertensives |
| title_full_unstemmed | The effects of amlodipine on exercise performance in mild to moderate essential hypertensives |
| title_short | The effects of amlodipine on exercise performance in mild to moderate essential hypertensives |
| title_sort | effects of amlodipine on exercise performance in mild to moderate essential hypertensives |
| topic | Sports Science |
| url | http://hdl.handle.net/11427/26977 |
| work_keys_str_mv | AT gillieshuntercampbell theeffectsofamlodipineonexerciseperformanceinmildtomoderateessentialhypertensives AT gillieshuntercampbell effectsofamlodipineonexerciseperformanceinmildtomoderateessentialhypertensives |